Canada, long regarded a pioneer in drug policy reform, is now trying to move the needle on patient access to psilocybin, the active ingredient in “magic mushrooms.”
The country’s history with early cannabis legalization has placed it at the center of attention in the psychedelics scene, as patients, advocates and healthcare professionals seek to expand access to psychedelics-assisted therapy.
Since 2020, Health Canada has allowed over 50 patients and doctors to legally use psilocybin through special government-granted exemptions. However, pressure is building for alternative solutions that can guarantee access to more people in a more agile way.
Share this post
